![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Preinitiation |
Unique ID issued by UMIN | UMIN000040118 |
Receipt No. | R000045743 |
Scientific Title | Effects of sleep deprivation on the wake state instability |
Date of disclosure of the study information | 2020/04/09 |
Last modified on | 2020/04/09 |
Basic information | ||
Public title | Effects of sleep deprivation on the wake state instability | |
Acronym | Effects of sleep deprivation on the wake state instability | |
Scientific Title | Effects of sleep deprivation on the wake state instability | |
Scientific Title:Acronym | Effects of sleep deprivation on the wake state instability | |
Region |
|
Condition | ||
Condition | Healthy subject | |
Classification by specialty |
|
|
Classification by malignancy | Others | |
Genomic information | NO |
Objectives | |
Narrative objectives1 | To understand the effects of sleep deprivation on the wake state instability |
Basic objectives2 | Others |
Basic objectives -Others | To understand the effects of sleep deprivation on the cognitive performance |
Trial characteristics_1 | |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | 1. Psychomotor vigilance task
2. Time production task |
Key secondary outcomes | 1. Wakefulness
2. Subjective sleepiness / fatigue 3. Sleep architecture during sleep and sleep deprivation |
Base | |
Study type | Interventional |
Study design | |
Basic design | Cross-over |
Randomization | Randomized |
Randomization unit | Individual |
Blinding | Open -no one is blinded |
Control | No treatment |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | ||
No. of arms | 2 | |
Purpose of intervention | Prevention | |
Type of intervention |
|
|
Interventions/Control_1 | A. normal sleep
B. sleep deprivation The order of laboratory is (A, B). |
|
Interventions/Control_2 | A. normal sleep
B. sleep deprivation The order of laboratory is (B, A). |
|
Interventions/Control_3 | ||
Interventions/Control_4 | ||
Interventions/Control_5 | ||
Interventions/Control_6 | ||
Interventions/Control_7 | ||
Interventions/Control_8 | ||
Interventions/Control_9 | ||
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | 1. Those who do not have difficulty in filling out Japanese explanatory documents, consent forms, and survey forms
2. Those who can stay in the examination room on the 5th floor of the Innovation Medical Research Institute, University of Tsukuba 3. Those who have never been treated for mental illness or sleep disorder 4. Those who currently have no symptoms to be treated 5. Those who can visit the lab or return home by walking, public transportation, or pick-up by others Driving by themselves (including bicycles) after the experiment is not allowed. |
|||
Key exclusion criteria | . Those who are living irregular lives (Regular life: 21: 00 ~ 1: 00 going to bed, getting up from 6: 00 ~ 9: 00, sleeping 7 ~ 9 hours)
2. Thin (below BMI18.5) or obese (over BMI25) physique 3. Those who worked night shift (after 22:00) within the last 3 months 4. Those who have traveled to a country with a time difference of 3 hours or more within the last 3 months 5. Those who drink alcohol regularly (at least 40 g of pure alcohol [approximate: 2 cans of beer] twice a week or more) 6. Those who have a smoking habit 7. Those who have a daily caffeine intake of 300 mg or more (approximate: 5 cups of 150 mL coffee) 8. Those who may fall under 1. -7. above during the experiment period 9. Extreme eveningness type or extreme morningness type (Morningness-Eveningness Questionnaire score 30 points or less or 70 points or above) 10. Those whose Pittsburgh Sleep Questionnaire scores more than 5.5 11. Those whose Epworth sleepiness scale score of 11 or higher 12. Those who have a disease that may change suddenly or have a history 13. Those who have claustrophobic 14. Those who are pregnant or may be pregnant 15. Those who are under lactation 16. Those who are judged by the investigator to be inappropriate |
|||
Target sample size | 30 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | University of Tsukuba | ||||||
Division name | International Institute for Integrative Sleep Medicine (WPI-IIIS) | ||||||
Zip code | 305-0821 | ||||||
Address | Innovation Medical Research Institute 502, 1-2 Kasuga, Tsukuba, Ibaraki | ||||||
TEL | 029-859-1858 | ||||||
abe.takashi.gp@u.tsukuba.ac.jp |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | University of Tsukuba | ||||||
Division name | International Institute for Integrative Sleep Medicine (WPI-IIIS) | ||||||
Zip code | 305-0821 | ||||||
Address | Innovation Medical Research Institute 502, 1-2 Kasuga, Tsukuba, Ibaraki | ||||||
TEL | 029-859-1858 | ||||||
Homepage URL | |||||||
abe.takashi.gp@u.tsukuba.ac.jp |
Sponsor | |
Institute | International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba |
Institute | |
Department |
Funding Source | |
Organization | Japan Society for the Promotion of Science |
Organization | |
Division | |
Category of Funding Organization | Japanese Governmental office |
Nationality of Funding Organization | Japan |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | Clinical Research Ethics Review Committee, University of Tsukuba Hospital |
Address | 2-1-1 AmakuboTsukuba, Ibaraki 305-0005 |
Tel | 029-853-3914 |
jisedai@md.tsukuba.ac.jp |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions | 筑波大学国際統合睡眠医科学研究機構 International Institute for Integrative Sleep Medicine, University of Tsukuba (WPI-IIIS) |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Preinitiation | ||||||
Date of protocol fixation |
|
||||||
Date of IRB | |||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045743 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |